Healthcare Finance News February 9, 2024
Optum Rx is working with Calibrate to bring its medication management strategy to employers seeking GLP-1 covered benefits.
Rob MacNaughton has been named new chief executive officer of Calibrate, a clinician-guided, value-based obesity treatment program, and one of his first missions will be to solidify a relationship with Optum Rx as a strategic partner during the company’s enterprise-first growth phase.
MacNaughton assumes the role of CEO at Calibrate at a time when the company is pushing growth in enterprise clients. Enter Optum Rx, one the country’s largest pharmacy benefits managers (PBMs). Optum Rx is working with Calibrate to bring its cost-effective medication management strategy to employers seeking GLP-1 covered benefits.
In August 2023, Calibrate launched the program for one of...
Today's Sponsors
Today's Sponsor